#read
Sanofi plans new insulin production plant
Sanofi has confirmed plans to build a state-of-the-art insulin production facility in Frankfurt-Höchst. The plant, which will cost around 1.3 billion euros by 2029, is intended to secure the long-term supply of insulin and strengthen European security of supply.
01/08/2024
The project is being supported by the German government, the Hessian state government and the city of Frankfurt. The new plant will be built on an area of five football pitches and will replace the existing production facilities. The investment is subject to approval by the European Commission.
Article from "Sanofi" dated 01/08/2024The above texts, or parts thereof, were automatically translated from the original language text using a translation system (DeepL API).
Despite careful machine processing, translation errors cannot be ruled out.